NexusTrade Loading NexusTrade… Taking too long? Reload this page

About Zhengye Biotechnology Holding Limited Class A Ordinary Shares (ZYBT)

Zhengye Biotechnology Holding Limited engages in the research, development, manufacture, and sale of veterinary vaccines for livestock in China. The company offers vaccines for swine, cattle, goats, sheep, poultry, and dogs. Its veterinary vaccines include monovalent vaccine, polyvalent vaccine, combined vaccine, and combined and polyvalent vaccine. The company also develops vaccines for household animals. In addition, it exports its products to Vietnam, Pakistan, and Egypt. The company serves direct-end customers, including livestock farmers and local governments, as well as domestic distributors and exporting distributors. The company was founded in 2004 and is based in Jilin, China. Zhengye Biotechnology Holding Limited operates as a subsidiary of Securingium Holding Limited.

Ticker
ZYBT
Exchange
XNAS
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic

Company profile updated October 15, 2026.

Stored market snapshot

As of October 12, 2026. Daily closing data may differ from the live quote shown in the dashboard.

Stored daily close (USD)
$1.69
Company market capitalization (USD)
$80,091,425.44
Price / book
1.83×

Research ZYBT

Compare the company’s price history and fundamentals in the dashboard. Explore disclosed trading and ownership activity in these research collections: